20170406 Telix Logo.png
FDA Approves Phase II Kidney Cancer Therapy Study
September 13, 2021 18:41 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States Food and Drug...
20170406 Telix Logo.png
Telix and Merck to Commence Pan-Cancer Clinical Combination Studies
August 17, 2021 21:03 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has entered into a pan-cancer clinical collaboration...
20170406 Telix Logo.png
Telix and Merck KGaA, Darmstadt, Germany, to Commence Pan-Cancer Clinical Combination Studies
August 17, 2021 21:02 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has entered into a pan-cancer clinical collaboration...
20170406 Telix Logo.png
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
August 29, 2019 20:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
20170406 Telix Logo.png
Telixが日本で腎臓がん用画像診断薬の臨床治験を開始
August 29, 2019 20:00 ET | Telix Pharmaceuticals Limited
メルボルン, オーストラリア および京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
20170406 Telix Logo.png
Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging
October 14, 2018 18:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...
20170406 Telix Logo.png
Telix Pharmaceuticals, University of Melbourne and Peter Mac to Collaborate on Colorectal Cancer
August 23, 2018 19:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia, Aug. 24, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”) has today announced a research collaboration with the University of Melbourne...
20170406 Telix Logo.png
Telix and Nihon Medi-Physics to Collaborate on Renal Cancer Imaging for the Japanese Market MELBOURNE, Australia and KYOTO, Japan and TOKYO, Aug. 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company...
20170406 Telix Logo.png
Telix Pharmaceuticals and JFE Progress Japanese Manufacturing Partnership
July 25, 2018 19:00 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and TOKYO, July 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), an Australian biopharmaceutical company focused on the development...
20170406 Telix Logo.png
テリックス・ファーマシューティカルズとjfe、日本の製造パートナーシップを進める
July 25, 2018 19:00 ET | Telix Pharmaceuticals Limited
メルボルン , July 26, 2018 (GLOBE NEWSWIRE) -- および京都発 (グローブニューズワイヤ) -- 標的放射性医薬品または「分子標的放射線」 (MTR) ベースの診断用・治療用製品の開発に注力するオーストラリアのバイオ製薬会社であるテリックス・ファーマシューティカルズ (Telix Pharmaceuticals Limited、ASX:TLX)...